Precio de cierre
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
14,23 CNY | +1,86 % | -6,69 % | -20,50 % |
Resumen de negocios
Número de empleados: 508
Ventas por actividad
CNY en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Arachidonic Acid
73,1
%
| 256 | 66,2 % | 302 | 73,1 % | +18,22 % |
Docosahexaenoic Acid
19,2
%
| 65 | 16,7 % | 79 | 19,2 % | +23,09 % |
Sialic Acid
5,6
%
| 34 | 8,9 % | 23 | 5,6 % | -32,60 % |
Other Business
2,0
%
| 31 | 8,1 % | 8 | 2,0 % | -73,16 % |
Ventas por región
CNY en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
China
62,3
%
| 231 | 57,6 % | 271 | 62,3 % | +17,17 % |
Overseas
37,7
%
| 171 | 42,4 % | 164 | 37,7 % | -3,77 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
De Wei Yi
CEO | Chief Executive Officer | 59 | 22/09/04 |
Hua Biao Wang
DFI | Director of Finance/CFO | 59 | 22/09/04 |
Zhi Ming Wang
CTO | Chief Tech/Sci/R&D Officer | 55 | 22/09/04 |
Bin Du
BRD | Director/Board Member | 59 | 22/09/04 |
Fang Wang
IRC | Investor Relations Contact | 34 | 01/06/20 |
Xiang Yu Li
PRN | Corporate Officer/Principal | 46 | 27/12/21 |
Hua Rong Yi
SEC | Corporate Secretary | 48 | 29/03/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Yi fei Wang
BRD | Director/Board Member | 43 | 27/12/21 |
De Wei Yi
CEO | Chief Executive Officer | 59 | 22/09/04 |
Qi Liu
BRD | Director/Board Member | 47 | 27/12/21 |
Bin Du
BRD | Director/Board Member | 59 | 22/09/04 |
Hua Biao Wang
DFI | Director of Finance/CFO | 59 | 22/09/04 |
Yu Jun Wu
BRD | Director/Board Member | 39 | 01/04/15 |
Zhi Ming Wang
CTO | Chief Tech/Sci/R&D Officer | 55 | 22/09/04 |
Xiang Dong Chen
BRD | Director/Board Member | 61 | 27/12/21 |
Chun Li
BRD | Director/Board Member | 54 | 27/12/21 |
Jing Chen
BRD | Director/Board Member | 41 | 27/12/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 168 309 120 | 84 114 414 ( 49,98 %) | 0 | 49,98 % |
Información de la empresa
Cabio Biotech (Wuhan) Co., Ltd.
999 Gaoxin Avenue East Lake New Technology Dev Zone
430075, Wuhan
+
http://www.cabio.cnSector
Ventas por actividad
Ventas por región
Revisiones del BPA
Beneficios anuales - Tasa de sorpresa
Varia. 1 de ene. | Capi. | |
---|---|---|
-20,50 % | 324 M | |
+10,32 % | 7963,86 M | |
+3,46 % | 7480,38 M | |
-0,09 % | 5879,93 M | |
-6,49 % | 3673,59 M | |
-13,09 % | 3468,48 M | |
-14,94 % | 1161,36 M | |
-23,33 % | 1143,63 M | |
+10,13 % | 948 M | |
-12,01 % | 893 M |
- Bolsa de valores
- Acciones
- Acción 688089
- Empresa Cabio Biotech (Wuhan) Co., Ltd.